Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.20
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.30 (25.00%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results

11 Dec 2013 07:00

RNS Number : 1440V
Image Scan Holdings PLC
11 December 2013
 



11 DECEMBER 2013

 

 

IMAGE SCAN HOLDINGS PLC

('Image Scan' or the 'Company')

 

PRELIMINARY RESULTS

FOR THE YEAR ENDED 30 SEPTEMBER 2013

 

Image Scan, an AIM-listed specialist in the field of real-time x-ray imaging for the security and industrial inspection markets, announces Preliminary Results for the year ended 30 September 2013; a period that, whilst loss-making, has seen the broadening of the product base by incremental development, profitability restored in the second half of the year and a significantly increased order intake.

 

KEY POINTS

· Profitability restored in H2 with a profit of £92,000, resulting in an overall loss for the year of £297,000 (2012: profit £108,000)

· Annual order intake up 32% to £3.3m (2012: £2.5m)

· Revenue at £2.5m (2012: £4.3m)

· Gross margin of 37% (2012: 38%)

· Underlying gross margin, excluding exceptional nuclear costs, at 43%

· Overheads down 20% to £1.3m (2012: £1.6m)

· Restructuring of the business to reduce overall break-even point

· Second half profit of £92,000 compared to interim loss of £389,000

 

POST YEAR-END EVENTS

· Cumulative orders deliverable in H1 2014 of £1.4m

· Current cash balance of £428,000

· Shipment of significant multiple unit contract to Middle East

· Appointment of x-ray security sector professional as a consultant to advise on product and market positioning

 

Brian Emslie, Chairman of Image Scan, commented: "Having operated at break-even in four of the last five half year periods, it is disappointing to report a loss for 2013. Much of the loss derived from exceptional costs relating to a one-off contract that was taken three years ago in very difficult economic conditions when the Company was in need of additional revenue.

 

"Over the last four years the Company has made progress to stem the historic losses and reposition the Company to focus on sales of standard equipment. Broadening the product base has been achieved entirely through incremental development given limited cash availability. Having stabilised the Company, the Board is now considering what actions and investments need to take place for the Company to make a significant step-change."

 

-END-

Enquiries:

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

Brian Emslie, Chairman

Louise George, CEO

ir@ish.co.uk

 

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000

Mark Percy / Rick Thompson (Corporate Finance)

Richard Redmayne / Paul Jewell (Corporate Broking)

 

Yellow Jersey PR Limited Tel: +44 (0) 7768 537 739

Dominic Barretto / Kelsey Traynor

 

 

 

About Image Scan Holdings plc

 

Image Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time x-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the Axis range of baggage inspection systems; the FlatScan range of portable bomb and suspect package detection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet x-ray systems for laboratories and production lines. The Company is now broadening its scope to look at other key applications where its technology can be adopted, such as in the Medical devices industry. The Company was founded in 1996 and joined AIM in 2002.

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

CHAIRMAN'S STATEMENT

 

INTRODUCTION

I am pleased to report on the Preliminary Results for Image Scan for the year ended 30 September 2013.

 

Order intake during 2013 totalled £3.3m (FY12: £2.5million), an increase of 32%. Capitalising on the investment into product development in 2012, orders received included a repeat sale of two further small vehicle inspection systems to an existing customer targeted at customs and border control in South East Asia; an order for two industrial inspection systems to a new multinational customer in a market where the Company has a niche expertise; and several multiple unit contracts for both the portable and the baggage screening products into Africa and the Middle East.

 

Prior to the first half of this financial year the Company had effectively been operating at break even for the previous year and a half, so the interim loss of £390,000 in 2013 was clearly disappointing. However, profitability was restored again during the second half of the year with a profit of £92,000 resulting in an overall loss for the financial year ending 30 September 2013 of £297,000.

 

During the year the difficulties associated with delivering the one off nuclear contract resulted in excess costs to the business of £153,000. This contract has taken its toll on the business both financially and in terms of opportunity cost in tying up critical resources, which would otherwise have been used to support development of the core product range. In addition the restructuring carried out by the Board during the first half, to reduce ongoing operating costs by 20%, incurred an exceptional charge of £25,000. It should be noted that, had it not been for these two exceptional costs, the net loss for this year would have been reduced to £119,000 compared to the 2012 profit after tax of £108,000.

 

The Board is pleased that having significantly reduced operating costs through restructuring of the Company, profitability was restored in the second half of the year. The Board closely monitors the cash position of the Company and is focusing on taking measures to enhance the sustainability and value of the business.

 

BUSINESS REVIEW

 

The Board continues to review the Company's operations with the primary goal of achieving a sustainable and more sales and marketing led organisation. The Company is increasing its product range though incremental development of existing product platforms to provide more opportunities for recurrent product sales volumes, as opposed to large one-off contracts. The intention is to reduce the occurrence of anomalies as experienced in the first half of the year.

 

Ignoring the exceptional costs incurred in the first half of 2013, the Company has effectively traded at break-even for the past two and a half years. Further growth in revenues will depend on the development or acquisition of new products and services. The Board believes that continuing to focus on incremental development will only provide incremental improvement and that a more fundamental approach is now required. The Board has recently appointed a senior x-ray security sector professional to act as a consultant to work with the Board and the management team. He will review our core capabilities, existing product range and strategy and will make recommendations as to what actions and investments need to take place for the Company to make a significant step change.

 

Despite the performance of the Company this year the Board believes significant progress has been made despite the relatively limited cash position of the Company.

 

 

Brian S Emslie

Chairman 11 December 2013

 

 

CHIEF EXECUTIVE'S REPORT

FINANCIAL RESULTS

Revenue in the year ended 30 September 2013 of £2.5m (2012: £4.3m) derived 70% from the Security and 30% from the Industrial sector. Performance across both core sectors was down mainly due to commencing the year with a much lower opening order book of £0.4m (2012: £2.2m) and a comparatively slow start to the year. New orders in the first half were £0.8m compared to £2.5m in the second half, giving annual order intake of £3.3m (2012: £2.5m), across the whole product range.

 

Security revenue was underpinned by growing sales of the portable x-ray inspection system, but fell overall by 41% due to a shortfall in sales of the vehicle inspection system. On the Industrial side, the level of sales of standard industrial equipment remained the same, but there was no further revenue arising from the nuclear contract.

 

The gross margin of 37% (2012: 38%) was suppressed by the impact of the exceptional excess costs in the year of £153,000 against the nuclear contract. Without these the underlying margin would have been 43% which is a fairer reflection of the Company's performance.

 

Overheads at £1.3m (2012: £1.6m) have dropped back in-line with previous years following the significant additional investment into product development last year. Furthermore, in view of the repositioning of the Company away from one-off sales such as the nuclear contract and towards sales of standard equipment, the Company was restructured accordingly with an approximate 20% saving flowing through into the last quarter of the financial year. The one-off cost associated with the restructuring was £25,000.

 

The reported losses after taxation of £389,000 in the interims reflected the low level of the opening order book and new orders in the first half of the year. Whilst the intake of new orders in the second half was much stronger, the lead time for key components has meant that a significant proportion of these sales will now fall into the first half of 2014 resulting in a closing order book of £1.2m (2012: £0.4m). As a result, the profit in the second half of the year was £92,000 which leaves an overall loss for the year of £297,000 (2012: Profit £108,000). The loss per share was 0.39p (2012: profit per share 0.14p).

 

The year-end cash balance was £12,000 (2012: £74,000). The Company retains a £100,000 overdraft facility with the Royal Bank of Scotland. The cash at bank as of 10 December 2013 was £428,000.

OUTLOOK

 

The Company continues to incrementally develop its product range and during 2014 is intending to introduce a new vehicle screening system and also to offer a number of combinations of different x-ray panels and generators to the portable screening market. Whilst industrial sales form a smaller part of the overall revenue, it is an area where the Company intends to invest in the necessary sales resource and product customisation to exploit the opportunities further, building on our expertise and traction in certain markets. The brought forward order book of £1.2m and new orders of £0.2m in the year to date give cumulative orders of £1.4m deliverable in the first half of 2014.

STAFF

During the period under review the Company underwent a restructuring process with a view to ensuring that the Company had the right mix of skills relevant to the business going forward. The Company intends to adopt a performance related reward strategy with the introduction of a profit-based staff bonus scheme and the issue of share options to incentivise staff and to promote good staff retention.

 

The Board values greatly the considerable efforts made by our staff and I would like to take this opportunity to personally thank staff and shareholders for their continued commitment to the Company.

 

 

Louise J George

Chief Executive Officer

11 December 2013

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 30 September 2013

 

 

 

 

2013

£

2012

£

 

 

 

 

 

 

 

 

Continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

 

 

2,537,786

4,301,983

 

Cost of sales

 

 

 

(1,586,820)

(2,647,129)

 

 

 

 

 

 

 

 

Gross profit

 

 

 

950,966

1,654,854

 

 

 

 

 

 

 

 

Administrative expenses

(1,292,856)

(1,624,063)

 

 

 

 

 

 

 

 

 

 

OPERATING (LOSS)/PROFIT

 

 

 

(341,890)

30,791

 

 

 

 

 

 

 

 

Finance income

 

 

 

80

880

 

 

 

 

 

 

 

 

(LOSS)/PROFIT BEFORE TAXATION

 

 

 

(341,810)

31,671

 

 

 

 

 

 

 

 

Taxation

 

 

 

45,155

76,314

 

 

 

 

 

 

 

 

LTOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM CONTINUING OPERATIONS TO THE EQUITY OWNERS OF THE PARENT COMPANY

 

 

 

 

 

(296,655)

 

107,985

 

 

 

 

 

 

 

 

 

 

EARNINGS PER SHARE

 

 

 

2013

£

2012

£

 

 

 

 

 

 

(Loss)/profit for the year

 

 

 

(296,655)

107,985

 

 

 

 

 

 

Weighted average number of ordinary shares in issue

 

 

76,267,932

76,267,932

 

 

 

 

 

 

Basic and diluted (loss)/earnings per share

 

 

 

(0.39p)

0.14p

 

 

 

 

 

 

 

IAS 33 requires presentation of diluted earnings per share ('EPS') when a company could be called upon to issue shares that would decrease net profit or increase net loss per share. Earnings or loss per share would not be affected by the exercise of out-of-the-money options since it is inappropriate to assume that option holders would act irrationally. Accordingly as there are no other diluting future share issues, diluted EPS is equal to basic EPS.

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2013

 

 

 

 

2013

£

2012

£

NON-CURRENT ASSETS

 

 

 

 

 

Property, plant and equipment

 

 

 

21,987

39,234

Other intangible assets

 

 

 

-

-

 

 

 

 

 

 

 

 

 

 

21,987

39,234

CURRENT ASSETS

 

 

 

 

 

Inventories

 

 

 

458,898

412,950

Trade and other receivables

 

 

 

1,119,944

1,121,490

Cash and cash equivalents

 

 

 

11,573

73,782

Current tax asset

 

 

 

36,064

75,385

 

 

 

 

 

 

 

 

 

 

1,626,479

1,683,607

 

 

 

 

 

 

TOTAL ASSETS

 

 

 

1,648,466

1,722,841

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

Trade and other payables

 

 

 

927,795

699,962

Warranty provision

 

 

 

43,151

46,140

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

 

970,946

746,102

 

 

 

 

 

 

 

NET ASSETS

 

 

 

 

677,520

 

976,739

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

Share capital

 

 

 

762,679

762,679

Share premium account

 

 

 

7,501,105

7,501,105

Retained losses

 

 

 

(7,586,264)

(7,287,045)

 

 

 

 

 

 

TTOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

 

 

 

 

677,520

 

 

976,739

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Year ended 30 September 2013

 

 

Share capital

£

Share premium

£

Retained earnings

£

 

Total

£

As at 1 October 2011

 

762,679

7,501,105

(7,392,308)

871,476

Profit for the year

-

-

107,985

107,985

Share-based transactions

-

-

(2,722)

(2,722)

 

 

 

 

 

As at 30 September 2012

 

762,679

7,501,105

(7,287,045)

976,739

 

Loss for the year

-

-

(296,655)

(296,655)

 

Share-based transactions

-

-

(2,564)

(2,564)

 

 

 

 

 

 

 

As at 30 September 2013

 

762,679

7,501,105

(7,586,264)

677,520

 

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

For the year ended 30 September 2013

 

 

 

 

2013

£

2012

£

Cash flows from operating activities

 

 

 

 

Operating (loss)/profit

 

 

(341,890)

30,791

Adjustments for:

 

 

Depreciation

 

 

21,472

33,435

Transfer of fixed assets to stock

 

 

4,293

-

Increase in inventories

 

 

(45,948)

(97,500)

Decrease/(increase) in trade and other receivables

1,546

(554,857)

Increase/(decrease) in trade and other payables

 

 

224,252

(282,727)

Share-based payments

 

 

(2,564)

(2,722)

 

 

 

 

 

Net cash used in operating activities

 

 

(138,839)

(873,580)

 

 

 

Corporation tax recovered

 

 

85,068

30,403

 

 

 

 

 

Net cash outflow from operating activities

 

 

(53,771)

(843,177)

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Interest received

 

 

80

880

Purchase of property, plant and equipment

 

 

 

(8,518)

(29,122)

 

 

 

 

 

Net cash outflow from investing activities

 

 

(8,438)

(28,242)

 

 

 

 

 

 

 

 

 

 

Net DECREASE in cash and cash equivalents

(62,209)

(871,419)

Cash and cash equivalents at beginning of year

 

 

73,782

945,201

 

 

 

 

 

Cash and cash equivalents at end of year

 

 

11,573

73,782

 

 

 

 

 

Notes to the preliminary statement

 

1 Basis of preparation

The financial information set out above does not constitute the Company's statutory accounts for the years ended 30 September 2013 and 30 September 2012 but is derived from those accounts. Statutory accounts for 2012 have been delivered to the Registrar of Companies and those for 2013 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under Section 498 of the Companies Act 2006.

2 IFRS 2 'Share-based payments'

Operating expenses includes a credit of £2,564 (2012 credit of £2,722) after valuation of the Company's employee share options schemes in accordance with IFRS 2 'Share-based payments'. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These items have been added back in the statement of changes in equity.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GGGUUPUPWGUU
Date   Source Headline
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.